Celldex stock price

Feb 21, 2020 · Celldex Therapeutics (NASDAQ:CLDX) initiated with Overweight rating and $8 (252% upside) price target at Cantor Fitzgerald. Shares up 10% premarket. Editas

9 Mar 2016 CLDX's stock share price has done very poorly compared to where it was a year ago: Despite any rallies, the net result is that it is down by  5 May 2016 CLDX's stock share price has done very poorly compared to where it was a year ago: Despite any rallies, the net result is that it is down by  Celldex Therapeutics, Inc. (NASDAQ: CLDX) Share Price and News. Celldex Therapeutics is a biopharmaceutical company, which applies its Precision  Celldex Therapeutics, Inc. (CLDX) Stock Price, Quote ... Find the latest Celldex Therapeutics, Inc. (CLDX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Find the latest Celldex Therapeutics, Inc. (CLDX) stock quote, history, news and other vital information to help you with your stock trading and investing.

CLDX - Celldex Therapeutics Stock Price - Barchart.com 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Celldex Therapeutics About Us Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline includes immunotherapies and other targeted biologics derived from a broad set of complementary technologies which have the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases. CLDX: Celldex Therapeutics Inc - Stock Price, Quote and ...

CLDX Stock Summary. With a one year PEG ratio of 0.79, Celldex Therapeutics Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than merely 9.01% of US stocks.

Celldex Therapeutics, Inc. - TheStreet - Stock Market Celldex Therapeutics (CLDX) Stock Up on Q2 Results. By Kaya Yurieff. Aug 9, 2016 1:45 PM EDT. MARKETS. Celldex Therapeutics (CLDX) Is Strong On High Volume Today. By TheStreet Wire. CLDX - Stock quote for CELLDEX THERAPEUTICS, INC. - MSN Money Apr 03, 2020 · View the latest CLDX stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of CELLDEX THERAPEUTICS, INC.. Celldex Therapeutics Inc. Stock Price (CLDX) | Barron's

CLDX:NASDAQ CM Stock Quote - Celldex Therapeutics Inc ...

CLDX Price Target and Analyst Ratings (Celldex Therapeutics)

Feb 08, 2019 · The reverse stock split will not alter any stockholder's percentage ownership interest in Celldex, except to the extent that the reverse stock split results in fractional shares.

Celldex Therapeutics, Inc. (CLDX) Stock Analysis & News ... Get breaking news and analysis on Celldex Therapeutics, Inc. (CLDX) stock, price quote and chart, trading and investing tools.

Celldex Therapeutics Inc (CLDX) Quote | Morningstar Apr 02, 2020 · Learn about CLDX with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to …